Agios Pharmaceuticals, Inc. (AGIO)

Agios Pharmaceuticals (AGIO) is highlighted in a biotech catalyst watchlist for upcoming Phase 2b trials, amidst mixed Phase [--] results for its sickle cell drug.

About Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals is a biopharmaceutical company focused on developing therapies for rare genetic diseases and cancer.
Agios Pharmaceuticals, Inc. uses the ticker $AGIO for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Agios Pharmaceuticals, Inc. (AGIO) social dominance is up 210.71% from the previous month.
Agios Pharmaceuticals, Inc. (AGIO) creators is up 77.5% from the previous week.
Agios Pharmaceuticals, Inc. (AGIO) engagements is up 312.63% from the previous week.
Agios Pharmaceuticals, Inc. (AGIO) mentions is up 122.78% from the previous week.
Agios Pharmaceuticals, Inc. (AGIO) posts created is up 400% from the previous week.

Price: $28

Price 24-Hour Time-Series Raw Data
The stock price has seen a slight decrease due to mixed Phase [--] trial results for its sickle cell drug, but a recent surge in social media sentiment and engagement suggests a potential for recovery.

24-Hour: -2.61% 7-Day: 7.21% 30-Day: 2.83%

1-Year High: $45.50 on 2025-11-18
1-Year Low: $22.30 on 2025-11-19

AltRank: [-----]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Agios Pharmaceuticals, Inc. (AGIO) is currently AltRank #1,033 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [---] [----]
[--] Month: [---] [----]
[--] Months: [---] [----]
[--] Year: [---] [---]
1-Year High: [-----] on 2026-02-04
1-Year Low: [--] on 2025-12-20

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] +5
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-06-26
1-Year Low: [--] on 2025-08-28

Engagements: [------] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [-----]
[--] Week: [-------] +313%
[--] Month: [-------] -53%
[--] Months: [---------] +218%
[--] Year: [---------] -32%
1-Year High: [-------] on 2025-11-19
1-Year Low: [--] on 2025-04-20

Engagements by network (24h): X: [------] YouTube: [--] Reddit: [--]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +123%
[--] Month: [---] -45%
[--] Months: [-----] +36%
[--] Year: [-----] -32%
1-Year High: [---] on 2025-11-26
1-Year Low: [--] on 2025-04-19

Mentions by network (24h): X: [--] YouTube: [--] Reddit: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Agios Pharmaceuticals, Inc. (AGIO) in the last [--] hours which is down 65% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [--] +78%
[--] Month: [---] -53%
[--] Months: [---] -14%
[--] Year: [-----] +116%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-04-22

The most influential creators that mention Agios Pharmaceuticals, Inc. in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@BiopharmIQ	[--]	[------]	[--]	[------]
@Jamce1182025	[--]	[--]	[--]	[--]
@SeanValenc89161	[--]	[---]	[--]	[--]
@it2mr0	[--]	[-----]	[--]	[--]

Sentiment: 100%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 100%
Daily Average: 75%
[--] Week: 100% no change
[--] Month: 100% +57%
[--] Months: 100% no change
[--] Year: 100% +50%
1-Year High: 100% on 2025-02-22
1-Year Low: 12% on 2025-09-08

Most Supportive Themes:

Biotech Stock Catalyst Watchlist: (90%) Focuses on upcoming Phase [--] and Phase [--] clinical trial readouts for various biotechnology stocks.

Most Critical Themes:

Sickle Cell Drug Trial Results: (10%) Mixed Phase [--] trial results for Agios' sickle cell drug are impacting the stock price.

Social Dominance: 0.00191%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00191%
Daily Average: 0.00845%
[--] Week: 0.00703% +0.00453%
[--] Month: 0.0087% +0.0059%
[--] Months: 0.0087% +0.0048%
[--] Year: 0.0087% -0.000700000000000001%
1-Year High: 0.052% on 2025-11-26
1-Year Low: 0.0016% on 2026-02-07

Market Dominance: 0.00185%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00185%
Daily Average: 0%
1-Year High: 0.085% on 2025-11-18
1-Year Low: 0.00185% on 2026-02-16

Market Cap: $1,632,203,598

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $1,632,203,598
Daily Average: $1,929,099,432
[--] Week: $1,639,994,894 +5.10%
[--] Month: $1,638,237,129 +3.30%
[--] Months: $1,638,237,129 -23%
[--] Year: $1,638,237,129 -14%
1-Year High: $2,652,695,308 on 2025-11-18
1-Year Low: $1,302,730,560 on 2025-11-19

Top Agios Pharmaceuticals, Inc. Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"When the leaderboard looks like this you know the room is on fire. Come see it for yourself on Xtrades. Follow like-minded traders and see what theyre trading $chnr $app $frog $shak $lrmr $agio $holo $clsk $crm $vtvt https://bit.ly/XtradesSignals https://bit.ly/XtradesSignals"
X Link @TradingXtrades 2026-02-16T06:25Z [----] followers, [---] engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q1 [----] 📈 $BIVI Phase [--] $MDNAF Phase 2b $DBVT Phase [--] $GOSS Phase [--] $MLTX Phase [--] $BFRI Phase [--] $BCDA Phase [--] $KPTI Phase [--] $IOVA Phase [--] $XENE Phase [--] $AGIO Phase 2b $AVBP Phase [--] $ATAI Phase [--] $MLYS Phase [--] $TARA Phase [--] $CADL Phase 2a $ANRO Phase [--] $IMMP Phase [--] $PEPG Phase [--] $TBPH Phase [--] $CLDX Phase [--] $NVCR Phase [--] $VRDN Phase [--] $CMPX Phase 2/3 $IDYA Phase 2/3 $VXRT Phase 2b $OCUL Phase [--] $LSTA Phase 2b $PCSA Phase [--] $OCGN Phase [--] $APGE Phase [--] $CMPS Phase [--] $MBRX Phase [--] $KOD Phase [--] $ALZN Phase [--] $HELP Phase [--] $PVLA Phase [--] $INSM"
X Link @BiopharmIQ 2026-02-15T19:38Z 28.9K followers, [----] engagements

"🧬 Biopharma Weekly Recap 📝 This week in biotech: $NKTR AtD data and financing ignite upside debate GLP-1 pill surge boosts $NVO/$LLY M&A chatter builds and dense Q1 readouts drive volatility. See interesting posts/ppl to check out 👇 @AppleHelix 1/ There is some confusion with the reporting on $MRNA Refuse to File. @seedy19tron The Weekly 🌱 New: $anl $tern $cmps Increased: $abvx $nktr Unchanged: $nxtc $ovid $slno $cntx $pasg $dawn $lqda $rytm Decreased: Closed: $crvs (s) $apge (s) $asnd $ptn $cogt @Andre_AGTC My watch list near term catalysts @ResearchPulse1 Can UBT251 from NVO be a"
X Link @BiopharmIQ 2026-02-14T16:03Z 28.9K followers, 11.5K engagements

"#earnings before the open on Thursday February [--] [----] $NBIS $MLCO $HWM $BN $ZBRA $CROX $ZTS $BIRK $TU $PCG $QSR $BAX $AEP $AVNT $CHKP $BUD $H $HIMX $TRIP $VNT $IPGP $IRDM $LECO $KELYA $TRN $SPHR $STNG $TNET $PODC $DBD $EEFT $ETR $ABEV $BRKR $AGIO $ALNY $BDC $BGC $AMG $BTDR $CMRC $CNDT $CNR $EXC $FMCC $FTS $GEO $GTES $GVA $CBRE https://www.earningswhispers.com/calendar The most anticipated earnings releases for the week of February [--] [----] are @RobinhoodApp $HOOD @AppLovin $APP @coinbase $COIN @AsteraLabs $ALAB @nebiusai #NBIS @Shopify $SHOP @Vertiv $VRT @Pinterest $PINS @AristaNetworks $ANET"
X Link @eWhispers 2026-02-11T19:36Z 551.7K followers, 47.9K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing